IVOMEC PREMIX FOR SWINE DIN 01913085
Status: Cancelled Post Market
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: IVERMECTIN B1A
Available to quote
Health Canada record
| Active ingredient(s) | IVERMECTIN B1A 0.6 % |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1993 |
| Current status date | 17-Nov-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IVERMECTIN B1A
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01926950 | IVOMEC SR BOLUS FOR CATTLE | MERIAL CANADA INC | Bolus | IVERMECTIN B1A 1.72 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23350 | 2020-03-17 | New Drug Submission (NDS) | Administrative - Manufacturer Name Change |
| 7716 | 2006-01-30 | Supplement to a New Drug Submission (SNDS) | INCLUSION OF A 14-DAY WITHDRAWAL PERIOD FOR THE SUBJECT PRODUCT ADMINISTERED TO BREEDING SOWS |
| 6776 | 1998-05-08 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL CLAINS AGAINST THE THREADWORM |
| 6706 | 1997-12-23 | New Drug Submission (NDS) |